NPI registry status
Active
2026 NPPES data Family Nurse Practitioner NPI 1235740457
Verify on CMS → Teika Takedai
Family Nurse Practitioner in Washington, Pennsylvania.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 210,832 in Family Nurse Practitioner, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
1K
Medicare Part D claims · 355 beneficiaries · Family Nurse Practitioner avg: 1K
Generic prescribing
87%
generic claims · 11% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$51.62
3 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Teika Takedai filed 1,253 Medicare Part D claims in 2023 as a Family Nurse Practitioner in Washington, Pennsylvania, prescribing 87% generic.
- 1K
- Part D claims, 2023
- 87%
- generic prescribing
- $51.62
- industry payments (Sunshine Act)
- ≥78th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Teika Takedai
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1235740457), first enumerated 08/11/2020.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 1,253 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$51.62 in reported industry payments (3 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
Pennsylvania statewide board action statistics are published annually — these figures describe aggregate state activity, not Teika Takedai's individual license status. Verify directly with the state medical board.
Source: PA-BOM annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1235740457 · Family Nurse Practitioner
NPI-10 · ENUM-RECENT · TAX-MEGA · RX-MID · BOOK-MID · PHOTO-ENUM
- NPI-10 1235740457
- ENUM-RECENT 2020
- TAX-MEGA 211K Family Nurse
- RX-MID 1,253
- BOOK-MID 6,508 in Pennsylvania
- PHOTO-ENUM Valerie Siaha · 2020
Teika Takedai's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
1,253 ≥ 78th percentile 78% of 1,370,886 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2023
What does the federal data show about Teika Takedai?
Quality data not reportedPrimary specialty
Family Nurse Practitioner
Medicare Part D claims
1,253 3% vs specialty avg
Specialty distribution in Pennsylvania
How Family Nurse Practitioner compares to other specialties among Pennsylvania providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Family Nurse Practitioner. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1235740457 |
|---|---|
| Specialty | Family Nurse Practitioner |
| Gender | Female |
| NPI Issued | 08/11/2020 |
Hospital and facility affiliations
Facilities where Teika Takedai bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Main Line Healthcare
Wynnewood, PA
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Teika Takedai. Source: openpaymentsdata.cms.gov.
Total received
$52
Largest payer
Almatica Pharma LLC
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Pennsylvania PA-BOM 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~45K Pennsylvania medical licensees in 2023 - they are NOT specific to Teika Takedai. To verify Teika Takedai's current license status, search the PA-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
133
Total board actions, Pennsylvania 2023
Across 129 cases
2.96
Actions per 1,000 licensees
Pennsylvania statewide rate
probation
Most common action type
48 cases
PA-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Pennsylvania disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
Teika Takedai - brand share 11.0%
Family Nurse Practitioner average
11% brand-name claims vs 87% generic, on 1,253 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
1,253
Total Claims
$96K
Total Drug Cost
355
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 2,538
- Total Day Supply
- 72,299
- Brand vs Generic
- 11% brand / 87% generic
- Brand Drug Cost
- $71K
- Generic Drug Cost
- $23K
- Antibiotic Claims
- 64
Patient Demographics
- Average Patient Age
- 71.1 years
- Avg HCC Risk Score
- 1.17
- Gender Split
- 61% female / 39% male
- Age Distribution
- <65: 50, 65-74: 181, 75-84: 98, 85+: 26
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Teika Takedai prescribes most
Top Medicare Part D drugs by claim count, 2023
- Lisinopril
Lisinopril
93 claims
- Atorvastatin Calcium
Atorvastatin Calcium
67 claims
- Levothyroxine Sodium
Levothyroxine Sodium
49 claims
- Hydrochlorothiazide
Hydrochlorothiazide
44 claims
- Amlodipine Besylate
Amlodipine Besylate
38 claims
- Prednisone 33
Prednisone
33 claims
- Omeprazole 32
Omeprazole
32 claims
- Escitalopram Oxalate 31
Escitalopram Oxalate
31 claims
| Drug | Claims |
|---|---|
| Lisinopril | 93 |
| Atorvastatin Calcium | 67 |
| Levothyroxine Sodium | 49 |
| Hydrochlorothiazide | 44 |
| Amlodipine Besylate | 38 |
| Prednisone | 33 |
| Omeprazole | 32 |
| Escitalopram Oxalate | 31 |
| Fluticasone Propionate | 29 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 26 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Family Nurse Practitioner Overview
How Teika Takedai fits within the Family Nurse Practitioner landscape nationally.
210,832
Family Nurse Practitioner Providers in US
56
States with Family Nurse Practitioner
1,222
Avg Claims per Provider
Teika Takedai's 1,253 claims are above the specialty average of 1,222.
Nationwide Family Nurse Practitioner peers with similar MIPS or enrollment year
Two federal-record peer sets for Takedai, both outside Pennsylvania so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2020)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Family Nurse Practitioner Providers in Pennsylvania
Other clinicians with the same primary specialty enrolled in Pennsylvania, drawn from the same CMS NPPES roster as Takedai.
One of 6,508 Family Nurse Practitioner providers enrolled in Pennsylvania, 5 are shown here.
Mynga Abarca
Wynnewood, PA
Dr. Mackenzie Abate
CRNP
Philadelphia, PA
Dr. Sandra Abbey
CRNP
Carlisle, PA
Dr. Deborah Abbonizio
CRNP
Meadowbrook, PA
Dr. Amanda Abboud
FNP-BC
Springfield, PA
Compare Family Nurse Practitioner nationally: see state-by-state distribution →
Frequently Asked Questions
What is Teika Takedai's specialty? ▼
Teika Takedai specializes in Family Nurse Practitioner and practices in Washington, Pennsylvania.
How much does Teika Takedai prescribe under Medicare Part D? ▼
In 2023, Teika Takedai wrote 1,253 Medicare Part D claims totaling $96K in drug costs for 355 beneficiaries.
Where is Teika Takedai located? ▼
Teika Takedai is located at 95 LEONARD AVE STE 200, Washington, PA, 15301. Phone: (724) 223-3100.
What is Teika Takedai's NPI number? ▼
Teika Takedai's National Provider Identifier (NPI) is 1235740457, issued on 08/11/2020.
Does Teika Takedai prescribe more brand-name or generic drugs? ▼
Teika Takedai's prescribing is 11% brand-name and 87% generic drugs by claim count, with $71K in brand drug costs.
How many Family Nurse Practitioner providers are there in the US? ▼
There are 210,832 Family Nurse Practitioner providers across 56 states in the US. The average Family Nurse Practitioner provider writes 1,222 Medicare Part D claims per year.
What drugs does Teika Takedai prescribe most often? ▼
Based on 2023 Medicare Part D data, Teika Takedai's most frequently prescribed drugs include Lisinopril, Atorvastatin Calcium, Levothyroxine Sodium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Teika Takedai accept Medicare? ▼
Teika Takedai appears in CMS Medicare data with 1,253 Part D claims and 355 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Teika Takedai's credentials? ▼
Teika Takedai's NPI is 1235740457. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.